Amylin/DAP anticorps (N-Term)
Aperçu rapide pour Amylin/DAP anticorps (N-Term) (ABIN927970)
Antigène
Voir toutes Amylin/DAP (IAPP) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- IAPP antibody was raised in rabbit using the N terminal of IAPP as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
IAPP Blocking Peptide, (ABIN5614120), is also available for use as a blocking control in assays to test for specificity of this IAPP antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Amylin/DAP (IAPP) (Islet Amyloid Polypeptide (IAPP))
-
Autre désignation
- IAPP
-
Sujet
- Islet, or insulinoma, amyloid polypeptide is commonly found in pancreatic islets of patients suffering diabetes mellitus type II, or harboring an insulinoma. While the assosciation of amylin with the development of type II diabetes has been known for some time, a direct causative role for amylin has been harder to establish. Studies suggest that amylin, like the related beta-amyloid (Abeta) associated with Alzheimer's disease, can induce apoptotic cell-death in particular cultured cells, an effect that may be relevant to the development of type II diabetes. Synonyms: Polyclonal IAPP antibody, Anti-IAPP antibody, islet amyloid polypeptide antibody, AMYLIN antibody, DAP antibody, IAP antibody.
-
Pathways
- Hormone Activity, Feeding Behaviour
Antigène
-